Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Gibson Oncology,LLC is composed of proven academic researchers and bio tech entrepreneurs who are excited to be developing effective and safer novel oncology drugs to treat resistant cancers with a focus on children. Gibson, in collaboration with NCI and Purdue Research Foundation is developing one or more novel clinical candidate Aza drugs to inhibit the major oncogene referred to as cMyc, as well as TOPO 1 enzyme that are ke...
Gibson Oncology,LLC is composed of proven academic researchers and bio tech entrepreneurs who are excited to be developing effective and safer novel oncology drugs to treat resistant cancers with a focus on children. Gibson, in collaboration with NCI and Purdue Research Foundation is developing one or more novel clinical candidate Aza drugs to inhibit the major oncogene referred to as cMyc, as well as TOPO 1 enzyme that are key drivers of many human cancers.

List your booth number for exhibitions, ask us